Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Physiol Behav 52(1):185187
A recent systematic review of GLP-1 agonist exposure found that animal studies showed risks such as fetal growth restriction and skeletal abnormalities, and due to limited human data, experts recommend stopping these medications in both pregnancy and during breastfeeding
The injectable version will have to be injected SUBQ or IM
Please keep your upcoming appointments with your primary care provider or endocrine specialist to ensure we can review your treatment plan and determine the best course of action
Pricing, dosing, program length, and availability may vary based on individual medical evaluation, treatment goals, medication availability, pharmacy requirements, and clinical appropriateness
US$ 23.39
US$ 20.06
US$ 24.57
US$ 27.62
